Selective Inhibition of Inducible Nitric Oxide Synthase by Agmatine
Open Access
- 1 January 1995
- journal article
- Published by Elsevier in The Japanese Journal of Pharmacology
- Vol. 69 (3) , 285-287
- https://doi.org/10.1254/jjp.69.285
Abstract
Agmatine was about as potent as aminoguanidine to inhibit the activity of the inducible form of nitric oxide synthase (iNOS) in isolated rat aorta. Like aminoguanidine, agmatine was devoid of significant activity on the constitutive form of NOS. Agmatine inhibited the conversion of [3H]L-arginine in [3H]L-citrulline in partially purified iNOS from macrophages (IC50 = 262 +/- 39.9 microM). Thus, our data suggest that agmatine may act as endogenous inhibitor of iNOS.Keywords
This publication has 12 references indexed in Scilit:
- Agmatine: an Endogenous Clonidine-Displacing Substance in the BrainScience, 1994
- The Nitric Oxide Synthase Family of ProteinsJournal of Vascular Research, 1994
- Beneficial Circulatory Effect of L-ArginineThe Japanese Journal of Pharmacology, 1994
- Aminoguanidine selectively inhibits inducible nitric oxide synthaseBritish Journal of Pharmacology, 1993
- Inhibition of nitric oxide formation by guanidinesEuropean Journal of Pharmacology, 1993
- Reversible Inhibition of Inducible, but Not Constitutive, Nitric Oxide Synthase by NG-Nitro-L-Arginine in Rat AortaEndothelium, 1993
- Induction of nitric oxide synthase by lipoteichoic acid from Staphylococcus aureus in vascular smooth muscle cellsFEBS Letters, 1992
- Endothelium independent protective effect of NG-monomethyl-L-arginine on endotoxin-induced alterations of vascular reactivityLife Sciences, 1991
- Macrophage Cytotoxicity: Role for L-Arginine Deiminase and Imino Nitrogen Oxidation to NitriteScience, 1987
- Arginine: Biochemistry, Physiology, and Therapeutic ImplicationsJournal of Parenteral and Enteral Nutrition, 1986